anoctamin 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| chloride transport |
|
|
| chloride transport |
|
|
| chloride transport |
|
|
| phospholipase C-activating G protein-coupled receptor signaling pathway |
|
|
| phospholipase C-activating G protein-coupled receptor signaling pathway |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| nucleoplasm |
|
|
| plasma membrane |
|
|
| plasma membrane |
|
|
| plasma membrane |
|
|
| plasma membrane |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| signaling receptor binding |
|
|
| calcium-activated cation channel activity |
|
|
| intracellularly calcium-gated chloride channel activity |
|
|
| intracellularly calcium-gated chloride channel activity |
|
|
| intracellularly calcium-gated chloride channel activity |
|
| Gene Ontology |
|---|
| chloride channel activity |
| protein dimerization activity |
| InterPro |
|---|
| Anoctamin, dimerisation domain |
| Anoctamin, transmembrane domain |
| Anoctamin |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:13099 | Moyamoya disease |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026